195 related articles for article (PubMed ID: 29050536)
1. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
[TBL] [Abstract][Full Text] [Related]
2. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
[TBL] [Abstract][Full Text] [Related]
3. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
[TBL] [Abstract][Full Text] [Related]
4. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
5. Urinary podocalyxin: Is it a real index of disease activity in egyptian patients lupus nephritis?
Fayed A; Elnokeety MM; Elyamny M; Hammad H; Soliman DHA; Ahmed RA
Saudi J Kidney Dis Transpl; 2020; 31(6):1198-1205. PubMed ID: 33565431
[TBL] [Abstract][Full Text] [Related]
6. Excretion Patterns of Urinary Sediment and Supernatant Podocyte Biomarkers in Patients with CKD.
Fukuda A; Minakawa A; Sato Y; Shibata H; Hara M; Fujimoto S
Kidney360; 2022 Jan; 3(1):63-73. PubMed ID: 35368571
[TBL] [Abstract][Full Text] [Related]
7. Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.
Huang D; Wu X; Zheng W; Peng X; He X; Mo S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):161-7. PubMed ID: 22561433
[TBL] [Abstract][Full Text] [Related]
8. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
9. Value of immunohistochemical expression of podocalyxin in active lupus nephritis.
Behairy MA; Shakweer MM; El Said TW; ElGharbawy NH
Nefrologia (Engl Ed); 2018; 38(1):64-72. PubMed ID: 28757276
[TBL] [Abstract][Full Text] [Related]
10. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T
J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
12. Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury.
Hayashi T; Tokuriki S; Okuno T; Ohta G; Igarashi A; Ohshima Y
Pediatr Nephrol; 2017 Oct; 32(10):1891-1896. PubMed ID: 28439668
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
[TBL] [Abstract][Full Text] [Related]
14. Urinary sediment podocalyxin in children with glomerular diseases.
Kanno K; Kawachi H; Uchida Y; Hara M; Shimizu F; Uchiyama M
Nephron Clin Pract; 2003; 95(3):c91-9. PubMed ID: 14646369
[TBL] [Abstract][Full Text] [Related]
15. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
16. ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.
Zhu B; Li XF; Zhu XL; Lin Y; Zhong S; Zhu CF; Tang XL; Hu YQ; Cheng XX; Wang YJ
J Nephrol; 2014 Aug; 27(4):411-7. PubMed ID: 24737246
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of determining urinary podocalyxin level in children with primary nephrotic syndrome].
Liu T; Zhang BL; Li L
Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):332-5. PubMed ID: 22613101
[TBL] [Abstract][Full Text] [Related]
18. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for urinary podocyte excretion assessment in lupus nephritis?
Mansur JB; Sabino AR; Nishida SK; Kirsztajn GM
Ren Fail; 2016; 38(4):643-7. PubMed ID: 26906105
[TBL] [Abstract][Full Text] [Related]
20. Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.
Jog NR; Blanco I; Lee I; Putterman C; Caricchio R
Lupus; 2016 Dec; 25(14):1551-1557. PubMed ID: 27075010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
